Tumour size and outcomes after thermal ablation for small renal masses
In this study information from 432 people with small renal [...]
Biomarkers for immunotherapy outcomes for kidney cancer
This review in the journal Cereus is very technical, but [...]
Ipilimumab-nivolumab and axitinib-pembrolizumab combinations produce similar survival times
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
Gene signature points to prognosis in kidney cancer
Some new research that has come out of Sweden has [...]
Metastasectomy as a treatment option for patients with advanced kidney cancer
Metastases form when your cancer spreads to other organs and [...]
Stereotactic ablative radiotherapy for kidney cancer metastases outside the brain
Stereotactic ablative radiotherapy (SABR) is mostly used for the treatment [...]
Prediction of outcomes in patients with small renal masses
Most patients with small renal masses can be monitored safely [...]
Community diagnostic centres to tackle the COVID backlogs
Community diagnostic centres have been set up across England to [...]
Adjuvant pembrolizumab approved in Scotland
Yesterday is was announced that the Scottish Medicines Consortium (SMC) [...]
A modified nivolumab/ipilimumab dosing regimen
In this phase 3b/4 study, people with advanced kidney cancer [...]
